Skip to main content
SpringerLink
Log in

Stroke Risk Factors

  • Chapter
  • First Online:
Handbook of Clinical Nutrition and Stroke

Part of the book series: Nutrition and Health ((NH))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ADA:

American Diabetes Association

AF:

Atrial Fibrillation

ALLHAT:

Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial

CARASIL:

Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

CAS:

Carotid Artery Stenosis

HDL:

High Density of Lipoprotein

LDL:

Low-Density Lipoprotein

MELAS:

Mitochondrial Myopathy, Encephalopathy, Lactacidosis, and Stroke

OSA:

Obstructive Sleep Apnea

SHEP:

Systolic Hypertension in the Elderly Program

UKPDS:

United Kingdom Prospective Diabetes Study

WHR:

Waist-to-Hip Ratio

References

  1. Murphy S, Xu J, Kochanek K. http://www.cdc.gov/nchs/fastats/lcod.htm. 2012;60(4)(4).

  2. Del Zoppo GJ, Saver JL, Jauch EC, Adams Jr HP, American Heart Association Stroke Council. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009;40(8):2945–8.

    Article  PubMed  Google Scholar 

  3. Rojas JI, Zurru MC, Romano M, Patrucco L, Cristiano E. Acute ischemic stroke and transient ischemic attack in the very old-risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol. 2007;14(8):895–9.

    Article  PubMed  CAS  Google Scholar 

  4. Chen RL, Balami JS, Esiri MM, Chen LK, Buchan AM. Ischemic stroke in the elderly: an overview of evidence. Nat Rev Neurol. 2010;6(5):256–65.

    Article  PubMed  Google Scholar 

  5. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43–53.

    Article  PubMed  Google Scholar 

  6. Petrea RE, Beiser AS, Seshadri S, Kelly-Hayes M, Kase CS, Wolf PA. Gender differences in stroke incidence and poststroke disability in the Framingham heart study. Stroke. 2009;40(4):1032–7.

    Article  PubMed  Google Scholar 

  7. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, et al. The lifetime risk of stroke: estimates from the Framingham study. Stroke. 2006;37(2):345–50.

    Article  PubMed  Google Scholar 

  8. Lisabeth LD, Beiser AS, Brown DL, Murabito JM, Kelly-Hayes M, Wolf PA. Age at natural menopause and risk of ischemic stroke: the Framingham heart study. Stroke. 2009;40(4):1044–9.

    Article  PubMed  Google Scholar 

  9. Seshadri S, Beiser A, Pikula A, Himali JJ, Kelly-Hayes M, Debette S, et al. Parental occurrence of stroke and risk of stroke in their children: the Framingham study. Circulation. 2010;121(11):1304–12.

    Article  PubMed  Google Scholar 

  10. Knottnerus IL, Gielen M, Lodder J, Rouhl RP, Staals J, Vlietinck R, et al. Family history of stroke is an independent risk factor for lacunar stroke subtype with asymptomatic lacunar infarcts at younger ages. Stroke. 2011;42(5):1196–200.

    Article  PubMed  Google Scholar 

  11. Banerjee A, Silver LE, Heneghan C, Welch SJ, Mehta Z, Banning AP, et al. Relative familial clustering of cerebral versus coronary ischemic events. Circ Cardiovasc Genet. 2011;4(4):390–6.

    Article  PubMed  Google Scholar 

  12. Francis J, Raghunathan S, Khanna P. The role of genetics in stroke. Postgrad Med J. 2007;83(983):590–5.

    Article  PubMed  Google Scholar 

  13. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hauser WA, et al. Race-ethnic disparities in the impact of stroke risk factors: the northern Manhattan stroke study. Stroke. 2001;32(8):1725–31.

    Article  PubMed  CAS  Google Scholar 

  14. Kissela B, Schneider A, Kleindorfer D, Khoury J, Miller R, Alwell K, et al. Stroke in a biracial population: the excess burden of stroke among blacks. Stroke. 2004;35(2):426–31.

    Article  PubMed  Google Scholar 

  15. Kleindorfer D. Sociodemographic groups at risk: race/ethnicity. Stroke. 2009;40(3 Suppl):S75–8.

    Article  PubMed  Google Scholar 

  16. Kleindorfer DO, Khoury J, Moomaw CJ, Alwell K, Woo D, Flaherty ML, et al. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010;41(7):1326–31.

    Article  PubMed  Google Scholar 

  17. Howard G, Cushman M, Kissela BM, Kleindorfer DO, McClure LA, Safford MM, et al. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke. 2011;42(12):3369–75.

    Article  PubMed  Google Scholar 

  18. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(2):577–617.

    Article  PubMed  Google Scholar 

  19. Landau WM, Willey JZ, Elkind MS. Physical activity and risk of ischemic stroke in the Northern Manhattan study. Neurology. 2010;75(1):94. author reply 94.

    Article  PubMed  Google Scholar 

  20. Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, et al. Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation. 2007;116(9):1094–105.

    Article  PubMed  Google Scholar 

  21. Sattelmair JR, Kurth T, Buring JE, Lee IM. Physical activity and risk of stroke in women. Stroke. 2010;41(6):1243–50.

    Article  PubMed  Google Scholar 

  22. Williams PT. Reduction in incident stroke risk with vigorous physical activity: evidence from 7.7-year follow-up of the national runners’ health study. Stroke. 2009;40(5):1921–3.

    Article  PubMed  Google Scholar 

  23. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–7.

    Article  PubMed  Google Scholar 

  24. Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan stroke study. Stroke. 2003;34(7):1586–92.

    Article  PubMed  Google Scholar 

  25. Rautiainen S, Larsson S, Virtamo J, Wolk A. Total antioxidant capacity of diet and risk of stroke: a population-based prospective cohort of women. Stroke. 2012;43(2):335–40.

    Article  PubMed  CAS  Google Scholar 

  26. He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet. 2006;367(9507):320–6.

    Article  PubMed  Google Scholar 

  27. Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008;168(7):713–20.

    Article  PubMed  Google Scholar 

  28. Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types—a systematic review and meta-analysis. BMC Public Health. 2010;10:258.

    Article  PubMed  Google Scholar 

  29. Zakhari S. Alcohol and the cardiovascular system: molecular mechanisms for beneficial and harmful action. Alcohol Health Res World. 1997;21(1):21–9.

    PubMed  CAS  Google Scholar 

  30. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–220.

    Article  PubMed  Google Scholar 

  31. Bhat VM, Cole JW, Sorkin JD, Wozniak MA, Malarcher AM, Giles WH, et al. Dose-response relationship between cigarette smoking and risk of ischemic stroke in young women. Stroke. 2008;39(9):2439–43.

    Article  PubMed  Google Scholar 

  32. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke. The Framingham study. JAMA. 1988;259(7):1025–9.

    Article  PubMed  CAS  Google Scholar 

  33. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D’Agostino RB, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham heart study. JAMA. 2002;287(8):1003–10.

    Article  PubMed  Google Scholar 

  34. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.

    Article  PubMed  CAS  Google Scholar 

  35. Neal B, MacMahon S, Chapman N, Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000;356(9246):1955–64.

    Article  PubMed  CAS  Google Scholar 

  36. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265(24):3255–64.

    Article  Google Scholar 

  37. Flack JM, Nasser SA. Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). The Antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs. diuretic. Curr Hypertens Rep. 2003;5(3):189–91.

    Article  PubMed  Google Scholar 

  38. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277(9):739–45.

    Article  PubMed  CAS  Google Scholar 

  39. Cutler DM, Long G, Berndt ER, Royer J, Fournier AA, Sasser A, et al. The value of antihypertensive drugs: a perspective on medical innovation. Health Aff (Millwood). 2007;26(1):97–110.

    Article  Google Scholar 

  40. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22(8):983–8.

    Article  PubMed  CAS  Google Scholar 

  41. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet. 1998;352(9135):1167–71.

    Article  PubMed  CAS  Google Scholar 

  42. Feinberg WM. Anticoagulation for prevention of stroke. Neurology. 1998;51(3 Suppl 3):S20–2.

    Article  PubMed  CAS  Google Scholar 

  43. van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, et al. Oral anticoagulants vs. aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA. 2002;288(19):2441–8.

    Article  PubMed  Google Scholar 

  44. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285(22):2864–70.

    Article  PubMed  CAS  Google Scholar 

  45. Hart RG. Warfarin in atrial fibrillation: underused in the elderly, often inappropriately used in the young. Heart. 1999;82(5):539–40.

    PubMed  CAS  Google Scholar 

  46. Abraham ME, Marcy TR. Warfarin versus dabigatran: comparing the old with the new. Consult Pharm. 2012;27(2):121–4.

    Article  PubMed  Google Scholar 

  47. National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–421.

    Google Scholar 

  48. Centers for disease control and prevention. 2011 National Diabetes Fact Sheet. 2011; Available at: http://www.cdc.gov/diabetes/pubs/factsheet11.htm#citation.

  49. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65.

    Article  Google Scholar 

  50. Leppala JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke. 1999;30(12):2535–40.

    Article  PubMed  CAS  Google Scholar 

  51. Soyama Y, Miura K, Morikawa Y, Nishijo M, Nakanishi Y, Naruse Y, et al. High-density lipoprotein cholesterol and risk of stroke in Japanese men and women: the Oyabe study. Stroke. 2003;34(4):863–8.

    Article  PubMed  CAS  Google Scholar 

  52. Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685–96.

    Article  PubMed  CAS  Google Scholar 

  53. Amarenco P, Tonkin AM. Statins for stroke prevention: disappointment and hope. Circulation. 2004;109(23 Suppl 1):III44–9.

    PubMed  Google Scholar 

  54. O’Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson Jr SK, et al. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke. 1992;23(12):1752–60.

    Article  PubMed  Google Scholar 

  55. Autret A, Pourcelot L, Saudeau D, Marchal C, Bertrand P, de Boisvilliers S. Stroke risk in patients with carotid stenosis. Lancet. 1987;1(8538):888–90.

    Article  PubMed  CAS  Google Scholar 

  56. Roffi M, Sievert H, Gray WA, White CJ, Torsello G, Cao P, et al. Carotid artery stenting versus surgery: adequate comparisons? Lancet Neurol. 2010;9(4):339–41. author reply 341–2.

    Article  PubMed  Google Scholar 

  57. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080–111.

    Article  PubMed  Google Scholar 

  58. Punjabi NM, Newman AB, Young TB, Resnick HE, Sanders MH. Sleep-disordered breathing and cardiovascular disease: an outcome-based definition of hypopneas. Am J Respir Crit Care Med. 2008;177(10):1150–5.

    Article  PubMed  Google Scholar 

  59. Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet. 1985;2(8468):1325–6.

    Article  PubMed  CAS  Google Scholar 

  60. Di Tullio MR, Homma S, Jin Z, Sacco RL. Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (aortic plaque and risk of ischemic stroke) study. J Am Coll Cardiol. 2008;52(10):855–61.

    Article  PubMed  Google Scholar 

  61. Kim RJ, Becker RC. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J. 2003;146(6):948–57.

    Article  PubMed  CAS  Google Scholar 

  62. Hankey GJ, Eikelboom JW, van Bockxmeer FM, Lofthouse E, Staples N, Baker RI. Inherited thrombophilia in ischemic stroke and its pathogenic subtypes. Stroke. 2001;32(8):1793–9.

    Article  PubMed  CAS  Google Scholar 

  63. The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology. 1993;43(10):2069–73.

    Article  Google Scholar 

  64. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA. 2011;306(11):1241–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, 44195, USA

    Gursimran S. Kochhar M.D., Jennifer F. T. Jue M.D. & Craig Nielsen M.D.

Authors
  1. Gursimran S. Kochhar M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jennifer F. T. Jue M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Craig Nielsen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Craig Nielsen M.D. .

Editor information

Editors and Affiliations

  1. , Nutrition Support Team, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, 44195, Ohio, USA

    Mandy L. Corrigan

  2. , Nutrition Therapy, Cleveland Clinic, 9500 Euclid Ave. M17, Cleveland, 44195, Ohio, USA

    Arlene A. Escuro

  3. Center for Human Nutrition, Department of Gastroenterology, Cleveland Clinic, 9500 Euclid Ave. A51, Cleveland, 44195, Ohio, USA

    Donald F. Kirby

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kochhar, G.S., Jue, J.F.T., Nielsen, C. (2013). Stroke Risk Factors. In: Corrigan, M., Escuro, A., Kirby, D. (eds) Handbook of Clinical Nutrition and Stroke. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-380-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-380-0_3

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-379-4

  • Online ISBN: 978-1-62703-380-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation